This episode is part of our “Meet the CEO” interview series. In each installment, we will  chat with specialty pharmacy leaders shaping the future of the industry and the patient journey to discover their thoughts, predictions and reactions as we head toward 2020.

Michael CastagnaIn this episode, Michael Castagna, MBA, PharmD, CEO of biopharmaceutical company Mannkind Corporation, shares his perspective on innovation and how pharmaceutical manufacturers are navigating the changing landscape with Suzette DiMascio, CHE, CMCE, CPC, host of the Specialty Pharmacy Podcast.

Tune in to discover:

  • How Mannkind’s innovative culture helps drive the company’s success and decision making
  • Why challenges with access are impacting drug pricing and the patient journey
  • What proprietary, innovative delivery mechanisms Mannkind leverages to improve patient outcomes
  • Ideas to control costs and increase technology adoption throughout the industry
  • How academic and health systems can partner more strategically with manufacturers, especially during new drug launches

About Michael Castagna, MBA, PharmD

Michael Castagna serves on the board of directors and is the CEO of Mannkind Corporation. Dr. Castagna has over 20 years of experience in healthcare, pharmaceutical, biotech and specialty pharmacy industries. He joined MannKind from Amgen, Inc., where he spent over three years as Vice President, Global Commercial Lead for a portfolio of nine biosimilar drugs, and Vice President, Global Lifecycle Management. Prior to Amgen, Dr. Castagna, was Executive Director of Bristol-Myers Squibb’s Immunology franchise, where he served as co-lead to relaunch Orencia IV and launch Orencia SC, both rheumatoid arthritis drugs.

Before BMS, Dr. Castagna was with Sandoz (Novartis) as Vice President and Division Head for Biopharmaceuticals, North America, where he established the US Biologics Business Unit and relaunched its lead product, Omnitrope, a human growth hormone. Prior to Sandoz, Dr. Castagna held a variety of positions with EMD (Merck), Serono, Pharmasset and DuPont Pharmaceuticals.

About The Specialty Pharmacy Podcast

Join host Suzette DiMascio, CHE, CMCE, CPC, President and CEO of CSI Specialty Group, as she answers questions, addresses concerns and discusses the news you need to stay on top of the ever evolving world of specialty pharmacy. Tune in every episode to hear real world examples of the good, the bad and the outrageous from the experts at CSI Specialty Group, and to learn about the limitless growth opportunities available in the specialty pharmacy industry.